Advanced search
Publication Cover
International Journal of Psychiatry in Clinical Practice Volume 24, 2020 - Issue 4
Submit an article Journal homepage
1,103
Views
10
CrossRef citations to date
0
Altmetric
Review Articles

Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews

Mohsen Ghaffari Daraba School of Management & Information Sciences, Shiraz University of Medical Sciences, Shiraz, IranView further author information
,
Arvin Hedayatib Research Center for Psychiatry and Behavior Science, Shiraz University of Medical Sciences, Shiraz, IranView further author information
,
Elahe Khorasanic Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, IranView further author information
,
Mohsen Bayatid Health Human Resources Research Center, School of Management and Medical Informatics, Shiraz University of Medical Sciences, Shiraz, IranView further author information
&
Khosro Keshavarzd Health Human Resources Research Center, School of Management and Medical Informatics, Shiraz University of Medical Sciences, Shiraz, IranCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-5778-5502View further author information
ORCID Icon
Pages 357-370 | Received 22 Dec 2019, Accepted 09 Jun 2020, Published online: 15 Jul 2020

References

  • AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or nonrandomised studies of healthcare interventions, or both. Retrieved 25 July 2018, from http://www.amstar.ca/docs/AMSTAR-2.pdf
  • Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, et al. 2018. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet (London, England). 391, 1357–1366.
  • Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C. 2010. Sertraline versus other antidepressive agents for depression. Cochr Database Syst Rev. 4:Cd006117.
  • Cipriani A, Purgato M, Furukawa TA, Trespidi C, Imperadore G, Signoretti A, Churchill R, Watanabe N, Barbui C. 2012. Citalopram versus other anti-depressive agents for depression. Cochr Database Syst Rev. 7:Cd006534.
  • Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, Churchill R, Barbui C. 2009. Escitalopram versus other antidepressive agents for depression. Cochr Database Syst Rev. 2:Cd006532.
  • Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, Mager U, Thieda P, Gaynes BN, Wilkins T, et al. 2011. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med. 155(11):772–785.
  • Gartlehner G, Hansen RA, Reichenpfader U, Kaminski A, Kien C, Strobelberger M, Van Noord M, Thieda P, Thaler K, Gaynes B. 2011. Drug class reviews. In: Drug class review: second-generation antidepressants: final update 5 report. edition. Portland (OR): Oregon Health & Science University.
  • "Investing in treatment for depression and anxiety leads to fourfold return."   Retrieved 27 july 2017, from https://www.who.int/en/news-room/detail/13-04-2016-investing-in-treatment-for-depression-and-anxiety-leads-to-fourfold-return.
  • Khoo AL, Zhou HJ, Teng M, Lin L, Zhao YJ, Soh LB, Mok YM, Lim BP, Gwee KP. 2015. Network meta-analysis and cost-effectiveness analysis of new generation antidepressants. CNS Drugs. 29(8):695–712.
  • Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, Barbui C. 2013. Fluoxetine versus other types of pharmacotherapy for depression. Cochr Database Syst Rev. 7:Cd004185.
  • Montgomery S, Hansen T, Kasper S. 2011. Efficacy of escitalopram compared to citalopram: a meta-analysis. Int J Neuropsychopharm. 14(02):261–268.
  • National Collaborating Centre for Mental H 2010. The nice guideline on the treatment and management of depression in adults. In: Depression: the treatment and management of depression in adults (Updated Edition). Leicester (UK): British Psychological Society
  • Omori IM, Watanabe N, Nakagawa A, Akechi T, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA, Meta-Analysis of New Generation Antidepressants (MANGA) Study Group 2009. Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis. J Psychopharmacol (Oxford)). 23(5):539–550.
  • Omori IM, Watanabe N, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA. 2010. Fluvoxamine versus other anti-depressive agents for depression. Cochr Database Syst Rev. 3: Cd006114.
  • Purgato M, Papola D, Gastaldon C, Trespidi C, Magni LR, Rizzo C, Furukawa TA, Watanabe N, Cipriani A, Barbui C. 2014. Paroxetine versus other anti-depressive agents for depression. Cochr Database Syst Rev. 4:Cd006531.
  • Ramsberg J, Asseburg C, Henriksson M. 2012. Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model. PLoS One. 7(8):e42003.
  • Trkulja V. 2010. Is escitalopram really relevantly superior to citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials. Croat Med J. 51(1):61–73.
  • Wang Y, Yu LH, Xie J, Chen JJ, Wei QP. 2014. Comparative efficacies of fluoxetine and paroxetine in major depression across varying acute-phase treatment periods: a meta-analysis. Asia Pacific Psychiatry. 6(4):353–362.
  • WHO. Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO
  • World Health Day 2017. How to get involved. http://www.who.int/campaigns/world-health-day/2017/how-to-get-involved/en

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.